AOPEP
protein-codingaminopeptidase O (putative), the group of M1 metallopeptidases|MicroRNA protein coding host genes
Gene summary
This gene encodes a member of the M1 zinc aminopeptidase family. The encoded protein is a zinc-dependent metallopeptidase that catalyzes the removal of an amino acid from the amino terminus of a protein or peptide. This protein may play a role in the generation of angiotensin IV. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2010]
- C9orf3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~425.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: Neurologic
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Most individuals have been described as not responsive to levodopa therapy
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AOPEP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001193329.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 8 | 9 | |||
| missense | 24 | 1 | 25 | |||
| nonsense | 2 | 3 | 5 | |||
| start loss | 0 | |||||
| frameshift | 1 | 5 | 6 | |||
| splice donor/acceptor (+/-2bp) | 1 | 5 | 6 | |||
| Total | 4 | 8 | 30 | 8 | 1 | 51 |
Highest pathogenic variant AF is 0.00006009109
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001180258.1 | 15 | MANE Select | |
| Ensembl | ENSP00000364464.2 | 15 | MANE Select | |
| RefSeq | NP_001180260.1 | 7 | Standard | |
| RefSeq | NP_001372990.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Peptide hormone metabolism
- Metabolism of proteins
- Metabolism of Angiotensinogen to Angiotensins
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000375315
- Coding exons
- 15
- Length
- 360459
- Individuals with no LoFs
- 125628
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 119
- Defined
- 125748
- p
- 0.000477
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.461 | 411 | 438 | 0.938 | 0.0000237 | 5367 |
| Missense (PolyPhen) | 115 | 139.43 | 0.82477 | 1719 | ||
| Synonymous | 0.491 | 152 | 160 | 0.951 | 0.00000877 | 1556 |
| Loss of Function | 1.87 | 29 | 42.1 | 0.688 | 0.00000209 | 494 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00045 | 0.00043 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00071 | 0.00071 | rare |
| Finnish | 0.00061 | 0.00060 | rare |
| European (Non-Finnish) | 0.00065 | 0.00062 | rare |
| South Asian | 0.00014 | 0.000098 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Aminopeptidases catalyze the hydrolysis of amino acid residues from the N-terminus of peptide or protein substrates. Able to cleave angiotensin III to generate angiotensin IV, a bioactive peptide of the renin-angiotensin pathway. Not able to cleave angiotensin I and angiotensin II. May play a role in the proteolytic processing of bioactive peptides in tissues such as testis and heart. {ECO:0000269|PubMed:15687497}.;
Recessive Scores
- pRec
- 0.187
Intolerance Scores
- LoFtool
- 0.986
- RVIS EVS
- -0.11
- RVIS percentile EVS
- 45.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |